Envoy Medical (COCH) Convertible Debt (2022 - 2023)
Envoy Medical (COCH) reported Convertible Debt of $2.5 million for Q4 2023, down 92.51% on a YoY basis from $33.4 million in Q4 2022, and down 37.5% sequentially from $4.0 million in Q3 2023.
Envoy Medical (COCH) Convertible Debt (2022 - 2023) Analysis & Trends
Envoy Medical (COCH) has 2 years of Convertible Debt data on file, last reported at $2.5 million in Q4 2023.
- For the quarter ending Q4 2023, Convertible Debt fell 92.51% year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2023 stood at $2.5 million (down 92.51% YoY), and the FY2023 full-year result was $2.5 million, down 92.51% from the prior year.
- Convertible Debt eased to $2.5 million in Q4 2023, from $4.0 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $33.4 million in Q4 2022 to a low of $2.5 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 14.60 Mn |
| Dec 31, 2022 | 33.40 Mn |